Walgreens Boots Alliance has agreed a $6.5bn (£4.8bn) deal to sell its Alliance Healthcare wholesale business in order to focus on its retail operations.
The parent company for Boots confirmed that pharmaceutical wholesaler AmerisourceBergen will acquire the majority stake of the business for $6.28bn (£4.62bn) in cash and 2 million AmerisourceBergen shares.
In addition, the two companies have struck a commercial partnership, which will extend their US distribution deal by three years to 2029.
Alliance Healthcare UK, which is responsible for distributing medicines from sites in Beeston, Nottinghamshire, and Weybridge, Surrey, will also continue to act as a distribution partner until 2031, despite the sale.
Please sign in now if you have a subscription or are already registered with us.
Retail-Week.com provides premium, in-depth intelligence that helps retailers judge risks, spot opportunities and identify what they need to do to win in the digital economy.
Register today for a taste of our high-quality intelligence and enjoy:
Discover Retail Week register now
Please note, if you have recently purchased a subscription, it may take a few minutes before your account is updated.